ArticleCureus2026

Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study.

Nobue Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.